MED MEDIFAST INC

Overview and Growth

In fiscal 2025, MEDIFAST INC recorded $385.79M of revenue, net loss of $18.67M, and an operating cash inflow of $6.86M. The $385.79M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 36.0% below fiscal 2024 revenue of $602.46M, marking a top-line contraction. On a per-share basis, diluted EPS was -$1.70, which connects the reported earnings outcome with the company’s diluted share count. The per-share result recorded a 994.7% decrease from fiscal 2024 diluted EPS of $0.19. At period end, total assets were $247.97M, framing the scale of the company’s operating and financing commitments. Asset turnover was 1.56x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $275.19M as gross profit before recognizing operating expenses and other items. The gross-profit relationship equaled 71.3% of revenue, quantifying the portion retained before operating expenses were recognized. Operations produced a $14.21M operating loss before non-operating and tax effects. Relative to revenue, the operating deficit measured 3.7%, showing the shortfall after operating costs. The company ended the period with a net loss of $18.67M, extending the operating result through all remaining items. The net loss equaled 4.8% of revenue, showing the bottom-line deficit relative to the company’s sales base. The pretax result was a loss of $5.64M, establishing the deficit before tax effects. Measured against revenue, the pretax deficit represented 1.5%. Income tax expense totaled $13.03M, providing the reported tax component that separates pretax and after-tax earnings. The loss-to-equity relationship was 9.4%, placing the bottom-line deficit against shareholder capital. The loss-to-assets relationship was 7.5%, placing the bottom-line deficit against the company’s resource base. The bottom line deteriorated from $2.09M of income in fiscal 2024 to a $18.67M loss.

Liquidity and Capital Structure

The company held $247.97M of assets against $49.05M of liabilities and $198.92M of equity, revealing how the asset base was financed. The near-term balance sheet paired $201.68M of current assets with $42.96M of current liabilities at the reporting date. The current ratio was 4.69x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $89.30M, separating immediately recognizable cash resources from the rest of the current-asset base. Measured only with cash and equivalents, coverage of current liabilities was 207.9%, excluding receivables and other current assets. The liabilities-to-assets relationship was 19.8%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 36.0%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 12.8% lower than fiscal 2024 assets of $284.21M, measuring the company’s own balance-sheet change. Against $210.11M of equity in fiscal 2024, the current book-equity balance moved 5.3% and ended lower. Compared with $90.93M in fiscal 2024, the current cash balance moved 1.8% and finished lower.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $6.86M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Capital expenditures used $5.61M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital expenditures represented 81.8% of operating cash flow, leaving the remainder available as free cash flow. After capital spending, free cash flow was $1.25M, leaving cash available for debt reduction, shareholder returns, or further investment. Free cash flow represented 0.3% of revenue, linking post-investment cash generation with the company’s operating scale. Free cash flow equaled 0.5% of total assets, relating post-investment cash generation to the company’s resource base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.